Close Menu

NEW YORK (GenomeWeb) – A new survey suggests that cancer patients may not be getting genetic testing in time to make use of the results in informing their care.

The survey conducted by diagnostics data analytics firm Diaceutics and released to coincide with World Cancer Day also revealed that cancer patients, who tend to be some of the most motivated to educate themselves about the latest research and treatment advances, may have limited knowledge of precision medicine and find it difficult to understand genetic test results.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.